Skip to content

NUWE

Nuwellis, Inc.

NASDAQ · Healthcare · Medical - Devices · US

$0.54
−1.57%
Ask drillr

Year over year

Reported trailing growth

Revenue
+8.4%
EBITDA
+12.5%
EBIT
-28.2%
EPS
+93.6%
Free cash flow
-46.1%
Operating cash flow
-44.8%

Forward estimates

Based on analyst estimates

Revenue
-71.8%
EBITDA
+72.3%
EPS
+91.3%

Three-year CAGR

Revenue
-1.1%
EBITDA
+37.8%
EBIT
-1.1%
Net income
-56.9%
EPS
+90.9%
Free cash flow
-12.9%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026